Approval Year
Substance Class |
Protein
Created
by
admin
on
Edited
Sat Jun 26 16:52:11 UTC 2021
by
admin
on
Sat Jun 26 16:52:11 UTC 2021
|
Protein Sub Type | |
Sequence Type | COMPLETE |
Record UNII |
NQI5D806LC
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
P28223
Created by
admin on Sat Jun 26 16:52:19 UTC 2021 , Edited by admin on Sat Jun 26 16:52:19 UTC 2021
|
PRIMARY | |||
|
NQI5D806LC
Created by
admin on Sat Jun 26 16:52:19 UTC 2021 , Edited by admin on Sat Jun 26 16:52:19 UTC 2021
|
PRIMARY | |||
|
P28223
Created by
admin on Sat Jun 26 16:52:19 UTC 2021 , Edited by admin on Sat Jun 26 16:52:19 UTC 2021
|
PRIMARY |
From | To |
---|---|
1_148 | 1_227 |
1_349 | 1_353 |
Glycosylation Type | HUMAN |
Glycosylation Link Type | Site |
---|---|
N | 1_8 |
N | 1_38 |
N | 1_44 |
N | 1_51 |
N | 1_54 |
Related Record | Type | Details | ||
---|---|---|---|---|
|
INVERSE AGONIST->TARGET | |||
|
AGONIST -> TARGET | |||
|
AGONIST -> TARGET | |||
|
INHIBITOR -> TARGET | |||
|
INHIBITOR -> TARGET |
INHIBITOR
Ki
|
||
|
AGONIST -> TARGET | |||
|
INHIBITOR -> TARGET | |||
|
INHIBITOR -> TARGET |
MAJOR
Ki
|
||
|
RADIOLIGAND->TARGET | |||
|
RADIOLIGAND->TARGET | |||
|
INHIBITOR -> TARGET | |||
|
INHIBITOR -> TARGET | |||
|
INHIBITOR -> TARGET | |||
|
INHIBITOR -> TARGET | |||
|
INHIBITOR -> TARGET |
|
||
|
AGONIST -> TARGET |
all of the tryptamines, including DMT but with the exception of psilocin, were more potent agonists at the 5-HT2A receptor than LSD in the assay that was used in the present study. LSD and psilocin were 5-HT2A receptor partial agonists, with 28% and 16% activation efficacy, respectively, whereas all of the other compounds presented higher 5-HT2A receptor activation efficacies (up to >80% for DiPT and 5-MeO-MiPT).
EC50
|
||
|
ANTAGONIST->TARGET | |||
|
INHIBITOR -> TARGET | |||
|
RADIOLIGAND->TARGET | |||
|
INHIBITOR -> TARGET | |||
|
INHIBITOR -> TARGET | |||
|
AGONIST -> TARGET | |||
|
PARTIAL AGONIST->TARGET | |||
|
INHIBITOR -> TARGET | |||
|
AGONIST -> TARGET | |||
|
RADIOLIGAND->TARGET | |||
|
PARTIAL AGONIST->TARGET | |||
|
INHIBITOR -> TARGET | |||
|
INHIBITOR -> TARGET | |||
|
PARTIAL AGONIST->TARGET | |||
|
INHIBITOR -> TARGET | |||
|
WEAK INHIBITOR->TARGET |
Ki
|
||
|
INHIBITOR -> TARGET | |||
|
INHIBITOR -> TARGET | |||
|
INHIBITOR -> TARGET |
INHIBITOR
Ki
|
||
|
INHIBITOR -> TARGET | |||
|
INHIBITOR -> TARGET | |||
|
INHIBITOR -> TARGET | |||
|
INHIBITOR -> TARGET | |||
|
AGONIST -> TARGET | |||
|
INHIBITOR -> TARGET | |||
|
INHIBITOR -> TARGET | |||
|
INHIBITOR -> TARGET | |||
|
INHIBITOR -> TARGET | |||
|
INHIBITOR -> TARGET | |||
|
AGONIST -> TARGET | |||
|
RADIOLIGAND->TARGET | |||
|
AGONIST -> TARGET | |||
|
INHIBITOR -> TARGET | |||
|
INHIBITOR -> TARGET | |||
|
INHIBITOR -> TARGET | |||
|
ANTAGONIST->TARGET |
BINDING
Ki
|
||
|
INHIBITOR -> TARGET | |||
|
INHIBITOR -> TARGET | |||
|
INHIBITOR -> TARGET | |||
|
INHIBITOR -> TARGET | |||
|
AGONIST -> TARGET | |||
|
AGONIST -> TARGET | |||
|
PARTIAL AGONIST->TARGET | |||
|
INHIBITOR -> TARGET |
cell:CHO; ligand: 3-H-KETASERIN
BINDING
Ki
|
||
|
INHIBITOR -> TARGET | |||
|
INHIBITOR -> TARGET |
Ki
|
||
|
INVERSE AGONIST->TARGET |
AGONIST
Ki
|
||
|
INHIBITOR -> TARGET | |||
|
INHIBITOR -> TARGET | |||
|
AGONIST -> TARGET | |||
|
PARTIAL AGONIST->TARGET |
Ki
|
||
|
INHIBITOR -> TARGET | |||
|
INHIBITOR -> TARGET | |||
|
INHIBITOR -> TARGET | |||
|
INHIBITOR -> TARGET | |||
|
RADIOLIGAND->TARGET |
Name | Property Type | Amount | Referenced Substance | Defining | Parameters | References |
---|---|---|---|---|---|---|
MOL_WEIGHT | CHEMICAL |
|
||||
Molecular Formula | CHEMICAL |
|